RS56563B1 - Derivati c17 heteroarila oleanolne kiseline i postupci za njihovu upotrebu - Google Patents

Derivati c17 heteroarila oleanolne kiseline i postupci za njihovu upotrebu

Info

Publication number
RS56563B1
RS56563B1 RS20171140A RSP20171140A RS56563B1 RS 56563 B1 RS56563 B1 RS 56563B1 RS 20171140 A RS20171140 A RS 20171140A RS P20171140 A RSP20171140 A RS P20171140A RS 56563 B1 RS56563 B1 RS 56563B1
Authority
RS
Serbia
Prior art keywords
aromatic
atoms
carbon
group
ring
Prior art date
Application number
RS20171140A
Other languages
English (en)
Serbian (sr)
Inventor
Xin Jiang
Christopher F Bender
Melean Visnick
Original Assignee
Reata Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reata Pharmaceuticals Inc filed Critical Reata Pharmaceuticals Inc
Publication of RS56563B1 publication Critical patent/RS56563B1/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Epidemiology (AREA)
  • Lubricants (AREA)
  • Steroid Compounds (AREA)
RS20171140A 2012-09-10 2013-09-10 Derivati c17 heteroarila oleanolne kiseline i postupci za njihovu upotrebu RS56563B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261699199P 2012-09-10 2012-09-10
PCT/US2013/059015 WO2014040056A1 (en) 2012-09-10 2013-09-10 C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
EP13767175.6A EP2892911B1 (en) 2012-09-10 2013-09-10 C17-heteroaryl derivatives of oleanolic acid and methods of use thereof

Publications (1)

Publication Number Publication Date
RS56563B1 true RS56563B1 (sr) 2018-02-28

Family

ID=49253401

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20171140A RS56563B1 (sr) 2012-09-10 2013-09-10 Derivati c17 heteroarila oleanolne kiseline i postupci za njihovu upotrebu

Country Status (28)

Country Link
US (1) US20140088163A1 (forum.php)
EP (1) EP2892911B1 (forum.php)
JP (1) JP6272870B2 (forum.php)
KR (1) KR102237364B1 (forum.php)
CN (1) CN104768965B (forum.php)
AU (1) AU2013312102B2 (forum.php)
BR (1) BR112015005200B1 (forum.php)
CA (1) CA2882417C (forum.php)
CY (1) CY1119762T1 (forum.php)
DK (1) DK2892911T3 (forum.php)
EA (1) EA029069B1 (forum.php)
ES (1) ES2644615T3 (forum.php)
HR (1) HRP20171565T1 (forum.php)
HU (1) HUE036797T2 (forum.php)
IL (1) IL237638B (forum.php)
IN (1) IN2015DN01547A (forum.php)
LT (1) LT2892911T (forum.php)
ME (1) ME02911B (forum.php)
MX (1) MX366954B (forum.php)
NZ (1) NZ705213A (forum.php)
PL (1) PL2892911T3 (forum.php)
PT (1) PT2892911T (forum.php)
RS (1) RS56563B1 (forum.php)
SG (1) SG11201501800UA (forum.php)
SI (1) SI2892911T1 (forum.php)
SM (1) SMT201700501T1 (forum.php)
WO (1) WO2014040056A1 (forum.php)
ZA (1) ZA201501203B (forum.php)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2252283B9 (en) 2008-01-11 2019-03-20 Reata Pharmaceuticals, Inc. Synthetic triterpenoids and methods of use in the treatment of disease
EA019263B1 (ru) 2008-04-18 2014-02-28 Ритэ Фамэсутикл, Инк. Антиоксидативные модуляторы воспаления: производные олеанолевой кислоты с аминовыми и другими модификациями на с-17
NZ588708A (en) 2008-04-18 2012-09-28 Reata Pharmaceuticals Inc 2-cyano steroid derivatives including an anti-inflammatory pharmacore
TWI527788B (zh) 2010-12-17 2016-04-01 瑞塔醫藥有限責任公司 作為抗氧化發炎調節劑之吡唑及嘧啶三環烯酮
ES2634315T3 (es) 2012-04-27 2017-09-27 Reata Pharmaceuticals, Inc. Derivados de 2.2-difluoropropionamida de bardoxolona metilo, formas polimórficas y métodos de uso de los mismos
US9556222B2 (en) 2012-06-15 2017-01-31 Reata Pharmaceuticals, Inc. A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
US9512094B2 (en) 2012-09-10 2016-12-06 Reata Pharmaceuticals, Inc. C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
US9593074B2 (en) 2012-09-10 2017-03-14 Reata Pharmaceuticals, Inc. C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof
TWI649330B (zh) 2013-04-24 2019-02-01 艾伯維有限公司 甲基巴多索龍之2,2-二氟丙醯胺衍生物、其多晶形及其使用方法
WO2016130927A1 (en) 2015-02-12 2016-08-18 Reata Pharmaceuticals, Inc. Imidazolyl tricyclic enones as antioxidant iflammation modulators
EP3353190B1 (en) 2015-09-23 2021-03-17 Reata Pharmaceuticals, Inc. C4-modified oleanolic acid derivatives for inhibition of il-17 and other uses
NZ753546A (en) 2016-11-08 2022-10-28 Reata Pharmaceuticals Holdings Llc Methods of treating alport syndrome using bardoxolone methyl or analogs thereof
CN106632574B (zh) * 2016-12-07 2018-05-29 广东天键生物科技有限公司 一种化合物、其制备方法及用途
TWI831738B (zh) 2016-12-16 2024-02-11 美商瑞塔醫藥有限責任公司 用於抑制RORγ及其他用途的嘧啶三環烯酮衍生物
KR102295179B1 (ko) 2017-09-14 2021-08-30 피닉스 바이오테크놀러지 인코포레이티드. 바이러스 감염 치료를 위한 방법 및 조성물
MX2020002884A (es) 2017-09-14 2020-10-05 Phoenix Biotechnology Inc Método y composición neuroprotectora mejorada para tratar afecciones neurológicas.
CN112654610B (zh) 2018-06-15 2024-12-24 里亚塔医药公司 用于抑制IL-17和RORγ的吡唑和咪唑化合物
WO2019246461A1 (en) 2018-06-20 2019-12-26 Reata Pharmaceuticals, Inc. Cysteine-dependent inverse agonists of nuclear receptors ror-gamma/ror-gamma-t and methods of treating diseases or disorders therewith
EP3856755A4 (en) * 2018-09-28 2022-12-28 Sichuan Haisco Pharmaceutical Co., Ltd. Terpinoid derivatives and uses thereof
JP7695229B2 (ja) * 2019-07-19 2025-06-18 リアタ ファーマシューティカルズ インコーポレイテッド C17極性置換ヘテロ芳香族合成トリテルペノイドおよびその使用方法
KR20220151038A (ko) 2020-03-31 2022-11-11 피닉스 바이오테크놀러지 인코포레이티드. 코로나바이러스 감염 예방를 위한 조성물
EP4009981B1 (en) 2020-03-31 2023-08-16 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection
JP7214696B2 (ja) * 2020-10-01 2023-01-30 一般財団法人 化学物質評価研究機構 新規in vitro皮膚感作性試験法
EP4259155A1 (en) 2020-12-11 2023-10-18 Reata Pharmaceuticals Holdings, LLC Synthetic triterpenoids for use in therapy
US20240140986A1 (en) 2021-01-18 2024-05-02 Reata Pharmaceuticals, Inc. Synthetic ursolic acid derivatives and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326507B1 (en) * 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
US6974801B2 (en) * 2002-05-13 2005-12-13 The Trustees Of Dartmounth College Inhibitors and methods of use thereof
EP2252283B9 (en) 2008-01-11 2019-03-20 Reata Pharmaceuticals, Inc. Synthetic triterpenoids and methods of use in the treatment of disease
EA019263B1 (ru) * 2008-04-18 2014-02-28 Ритэ Фамэсутикл, Инк. Антиоксидативные модуляторы воспаления: производные олеанолевой кислоты с аминовыми и другими модификациями на с-17
US8071632B2 (en) 2008-04-18 2011-12-06 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: novel derivatives of oleanolic acid
BRPI0911422B8 (pt) * 2008-04-18 2021-05-25 Reata Pharmaceuticals Inc compostos moduladores inflamatórios antioxidantes, composição farmacêutica e usos dos mesmos
EP2279197B1 (en) * 2008-04-18 2014-11-05 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
RS59200B1 (sr) * 2011-03-11 2019-10-31 Reata Pharmaceuticals Inc Derivati c4-monometil triterpenoida i postupci za njihovu upotrebu
US9556222B2 (en) * 2012-06-15 2017-01-31 Reata Pharmaceuticals, Inc. A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof

Also Published As

Publication number Publication date
US20140088163A1 (en) 2014-03-27
MX2015003078A (es) 2015-07-14
EP2892911A1 (en) 2015-07-15
LT2892911T (lt) 2017-11-10
KR20150053982A (ko) 2015-05-19
EA201590539A1 (ru) 2015-08-31
CN104768965A (zh) 2015-07-08
CN104768965B (zh) 2018-05-11
ES2644615T3 (es) 2017-11-29
ZA201501203B (en) 2021-08-25
ME02911B (me) 2018-10-20
PT2892911T (pt) 2017-11-02
NZ705213A (en) 2018-07-27
AU2013312102B2 (en) 2018-03-08
CA2882417C (en) 2021-04-20
EP2892911B1 (en) 2017-08-30
AU2013312102A1 (en) 2015-03-12
BR112015005200B1 (pt) 2022-07-05
CA2882417A1 (en) 2014-03-13
SG11201501800UA (en) 2015-04-29
HRP20171565T1 (hr) 2017-12-15
PL2892911T3 (pl) 2018-03-30
BR112015005200A2 (forum.php) 2017-08-15
HK1211295A1 (en) 2016-05-20
CY1119762T1 (el) 2018-06-27
JP6272870B2 (ja) 2018-01-31
JP2015529227A (ja) 2015-10-05
SI2892911T1 (sl) 2017-12-29
DK2892911T3 (en) 2017-10-23
SMT201700501T1 (it) 2017-11-15
MX366954B (es) 2019-07-31
WO2014040056A1 (en) 2014-03-13
KR102237364B1 (ko) 2021-04-06
EA029069B1 (ru) 2018-02-28
IN2015DN01547A (forum.php) 2015-07-03
HUE036797T2 (hu) 2018-07-30
IL237638A0 (en) 2015-04-30
IL237638B (en) 2020-04-30

Similar Documents

Publication Publication Date Title
RS56563B1 (sr) Derivati c17 heteroarila oleanolne kiseline i postupci za njihovu upotrebu
US11406648B2 (en) C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
RS59194B1 (sr) C17-alkandiilni i alkendiilni derivati oleanolne kiseline i metode za njihovu upotrebu
US9278912B2 (en) C13-hydroxy derivatives of oleanolic acid and methods of use thereof
AU2012229244B2 (en) C4-monomethyl triterpenoid derivatives and methods of use thereof
EP2651902B1 (en) Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
WO2013188818A1 (en) A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
HK1211295B (en) C17-heteroaryl derivatives of oleanolic acid and methods of use thereof